+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Embolotherapy Market By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders), By Product, By Type, By End-User, By Region, Forecast & Opportunities, 2025

  • ID: 5022641
  • Report
  • May 2020
  • Region: Global
  • TechSci Research
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

FEATURED COMPANIES

  • Abbott Laboratories
  • Acandis GmbH
  • Cook Medical
  • Imbiotechnologies Ltd.
  • Kaneka Corporation
  • Merit Medical Systems
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Global Embolotherapy Market is expected to register significant CAGR during the forecast period owing to factors like rising incidence of chronic diseases, increasing patient pool and surging healthcare spending. Additionally, rapid technological advancements in embolotherapy devices is also anticipated to boost the market growth until 2025.

Embolotherapy is a type of endovascular treatment used for controlling bleeding and reduce tumor by restricting or blocking abnormal blood cells. To achieve blocking, embolotherapy uses minimally invasive methods and other embolic agents like gel foam, coils, balloons and angiographic catheters to achieve positive results. Additionally, adoption of embolic procedures for the management of various diseases is increasing rapidly as most of the patients who are diagnosed at intermediate stage and advanced stage, do not respond to curative therapies.

The Global Embolotherapy Market faces some restraints which include risks and challenges associated with embolization and dearth of skilled radiologists. Also, unfavorable regulatory scenario might also pose challenge to the growth of embolotherapy market.

The Global Embolotherapy Market is segmented based on indication, product, type, end-user and region. Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers and others. In 2019, hospitals category accounted for the largest market share in the Global Embolotherapy Market. The reason behind this can be attributed to growing adoption of minimally invasive procedures promoted by the hospitals.

Major players operating in the Global Embolotherapy Market include Abbott Laboratories , ABK Biomedical Inc, Acandis GmbH, AngioDynamics Inc, Becton Dickinson and Company, Boston Scientific Corporation, Cook Medical, Guerbet, Imbiotechnologies Ltd., Johnson & Johnson, Kaneka Corporation, Medtronic, Meril Life Sciences Pvt. Ltd., Merit Medical Systems, Inc., Penumbra, Inc., Simbionix USA Corporation, Sirtex Medical Limited, Stryker Corporation, Terumo Corporation and others. The companies are engaging in research and development of new products to increase their market share. Also, other growth strategies like partnerships, and strategic acquisitions are helping companies to boost their presence in the Global Embolotherapy Market.

Years considered for this report:
  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021–2025

Objective of the Study:
  • To analyze and forecast the market size of the Global Embolotherapy Market.
  • To classify and forecast the Global Embolotherapy Market based on indication, product, type, end-user and regional distribution.
  • To identify drivers and challenges for the Global Embolotherapy Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Embolotherapy Market.
  • To conduct pricing analysis for the Global Embolotherapy Market.
  • To identify and analyze the profile of leading players operating in the Global Embolotherapy Market.

The author performed both primary as well as exhaustive secondary research for this study. Initially, researchers sourced a list of hospitals/clinics across the globe. Subsequently, researchers conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, researchers could include the hospitals/clinics which could not be identified due to the limitations of secondary research. The author analyzed the hospitals/clinics and presence of all major players across the globe.

The author calculated the market size of the Global Embolotherapy Market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. Researchers sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied.

Key Target Audience:
  • Embolotherapy hospitals/clinics, research organizations and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to embolotherapy
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as hospitals/clinics, partners, end-users, etc., besides allowing them in strategizing investments and capitalizing on the market opportunities.

Report Scope:
In this report, the Global Embolotherapy Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

Market, By Indication:
  • Cancer
  • Gastrointestinal Disorders
  • Neurological Diseases
  • Peripheral Vascular Disease
  • Urological & Nephrological Disorders

Market, By Product:
  • Embolic Agents
  • Embolic Coils
  • Embolic Plug Systems
  • Liquid Embolic Agents
  • Microspheres
  • Detachable Balloons
  • Support Devices
  • Microcatheters
  • Guidewires

Market, By Type:
  • Chemoembolization
  • Radioembolization
  • Arterial Embolization
  • Combination

Market, By End-User:
  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Others

Market, By Region:
  • North America
  • United States
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Australia
  • Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • South America
  • Brazil
  • Argentina
  • Colombia

Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Embolotherapy Market.

Available Customizations:
With the given market data, researchers offers customizations according to a company’s specific needs.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories
  • Acandis GmbH
  • Cook Medical
  • Imbiotechnologies Ltd.
  • Kaneka Corporation
  • Merit Medical Systems

1. Product Overview2. Research Methodology3. Impact of COVID-19 on Global Embolotherapy Market4. Executive Summary5. Voice of Customer
6. Global Embolotherapy Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Indication (Cancer, Gastrointestinal Disorders, Neurological Diseases, Peripheral Vascular Disease, Urological & Nephrological Disorders)
6.2.2. By Product (Embolic Agents (Embolic Coils, Embolic Plug Systems, Liquid Embolic Agents, Microspheres, Detachable Balloons), Support Devices (Microcatheters, Guidewires))
6.2.3. By Type (Chemoembolization, Radioembolization, Arterial embolization, Combination)
6.2.4. By End-User (Hospitals, Clinics, Ambulatory Surgical Centers, Others)
6.2.5. By Company (2019)
6.2.6. By Region
6.3. Market Attractiveness Index
7. Asia-Pacific Embolotherapy Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Indication
7.2.2. By Embolic agents
7.2.3. By Types
7.2.4. By End-User
7.2.5. By Country
7.3. Market Attractiveness Index
7.4. Asia-Pacific: Country Analysis
7.4.1. China Embolotherapy Market Outlook
7.4.1.1. Market Size & Forecast
7.4.1.1.1. By Value
7.4.1.2. Market Share & Forecast
7.4.1.2.1. By Indication
7.4.1.2.2. By Embolic agents
7.4.1.2.3. By Types
7.4.1.2.4. By End-User
7.4.2. India Embolotherapy Market Outlook
7.4.2.1. Market Size & Forecast
7.4.2.1.1. By Value
7.4.2.2. Market Share & Forecast
7.4.2.2.1. By Indication
7.4.2.2.2. By Embolic agents
7.4.2.2.3. By Types
7.4.2.2.4. By End-User
7.4.3. Japan Embolotherapy Market Outlook
7.4.3.1. Market Size & Forecast
7.4.3.1.1. By Value
7.4.3.2. Market Share & Forecast
7.4.3.2.1. By Indication
7.4.3.2.2. By Embolic agents
7.4.3.2.3. By Types
7.4.3.2.4. By End-User
7.4.4. South Korea Embolotherapy Market Outlook
7.4.4.1. Market Size & Forecast
7.4.4.1.1. By Value
7.4.4.2. Market Share & Forecast
7.4.4.2.1. By Indication
7.4.4.2.2. By Embolic agents
7.4.4.2.3. By Types
7.4.4.2.4. By End-User
7.4.5. Singapore Embolotherapy Market Outlook
7.4.5.1. Market Size & Forecast
7.4.5.1.1. By Value
7.4.5.2. Market Share & Forecast
7.4.5.2.1. By Indication
7.4.5.2.2. By Embolic agents
7.4.5.2.3. By Types
7.4.5.2.4. By End-User
7.4.6. Australia Embolotherapy Market Outlook
7.4.6.1. Market Size & Forecast
7.4.6.1.1. By Value
7.4.6.2. Market Share & Forecast
7.4.6.2.1. By Indication
7.4.6.2.2. By Embolic agents
7.4.6.2.3. By Types
7.4.6.2.4. By End-User
8. Europe Embolotherapy Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Indication
8.2.2. By Embolic agents
8.2.3. By Types
8.2.4. By End-User
8.2.5. By Country
8.3. Market Attractiveness Index
8.4. Europe: Country Analysis
8.4.1. France Embolotherapy Market Outlook
8.4.1.1. Market Size & Forecast
8.4.1.1.1. By Value
8.4.1.2. Market Share & Forecast
8.4.1.2.1. By Indication
8.4.1.2.2. By Embolic agents
8.4.1.2.3. By Types
8.4.1.2.4. By End-User
8.4.2. Germany Embolotherapy Market Outlook
8.4.2.1. Market Size & Forecast
8.4.2.1.1. By Value
8.4.2.2. Market Share & Forecast
8.4.2.2.1. By Indication
8.4.2.2.2. By Embolic agents
8.4.2.2.3. By Types
8.4.2.2.4. By End-User
8.4.3. United Kingdom Embolotherapy Market Outlook
8.4.3.1. Market Size & Forecast
8.4.3.1.1. By Value
8.4.3.2. Market Share & Forecast
8.4.3.2.1. By Indication
8.4.3.2.2. By Embolic agents
8.4.3.2.3. By Types
8.4.3.2.4. By End-User
8.4.4. Italy Embolotherapy Market Outlook
8.4.4.1. Market Size & Forecast
8.4.4.1.1. By Value
8.4.4.2. Market Share & Forecast
8.4.4.2.1. By Indication
8.4.4.2.2. By Embolic agents
8.4.4.2.3. By Types
8.4.4.2.4. By End-User
8.4.5. Russia Embolotherapy Market Outlook
8.4.5.1. Market Size & Forecast
8.4.5.1.1. By Value
8.4.5.2. Market Share & Forecast
8.4.5.2.1. By Indication
8.4.5.2.2. By Embolic agents
8.4.5.2.3. By Types
8.4.5.2.4. By End-User
8.4.6. Spain Embolotherapy Market Outlook
8.4.6.1. Market Size & Forecast
8.4.6.1.1. By Value
8.4.6.2. Market Share & Forecast
8.4.6.2.1. By Indication
8.4.6.2.2. By Embolic agents
8.4.6.2.3. By Types
8.4.6.2.4. By End-User
9. North America Embolotherapy Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Indication
9.2.2. By Embolic agents
9.2.3. By Types
9.2.4. By End-User
9.2.5. By Country
9.3. Market Attractiveness Index
9.4. North America: Country Analysis
9.4.1. United States Embolotherapy Market Outlook
9.4.1.1. Market Size & Forecast
9.4.1.1.1. By Value
9.4.1.2. Market Share & Forecast
9.4.1.2.1. By Indication
9.4.1.2.2. By Embolic agents
9.4.1.2.3. By Types
9.4.1.2.4. By End-User
9.4.2. Mexico Embolotherapy Market Outlook
9.4.2.1. Market Size & Forecast
9.4.2.1.1. By Value
9.4.2.2. Market Share & Forecast
9.4.2.2.1. By Indication
9.4.2.2.2. By Embolic agents
9.4.2.2.3. By Types
9.4.2.2.4. By End-User
9.4.3. Canada Embolotherapy Market Outlook
9.4.3.1. Market Size & Forecast
9.4.3.1.1. By Value
9.4.3.2. Market Share & Forecast
9.4.3.2.1. By Indication
9.4.3.2.2. By Embolic agents
9.4.3.2.3. By Types
9.4.3.2.4. By End-User
10. South America Embolotherapy Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value & Volume
10.2. Market Share & Forecast
10.2.1. By Indication
10.2.2. By Embolic agents
10.2.3. By Types
10.2.4. By End-User
10.2.5. By Country
10.3. Market Attractiveness Index
10.4. South America: Country Analysis
10.4.1. Brazil Embolotherapy Market Outlook
10.4.1.1. Market Size & Forecast
10.4.1.1.1. By Value
10.4.1.2. Market Share & Forecast
10.4.1.2.1. By Indication
10.4.1.2.2. By Embolic agents
10.4.1.2.3. By Types
10.4.1.2.4. By End-User
10.4.2. Argentina Embolotherapy Market Outlook
10.4.2.1. Market Size & Forecast
10.4.2.1.1. By Value
10.4.2.2. Market Share & Forecast
10.4.2.2.1. By Indication
10.4.2.2.2. By Embolic agents
10.4.2.2.3. By Types
10.4.2.2.4. By End-User
10.4.3. Colombia Embolotherapy Market Outlook
10.4.3.1. Market Size & Forecast
10.4.3.1.1. By Value
10.4.3.2. Market Share & Forecast
10.4.3.2.1. By Indication
10.4.3.2.2. By Embolic agents
10.4.3.2.3. By Types
10.4.3.2.4. By End-User
11. Middle East and Africa Embolotherapy Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value & Volume
11.2. Market Share & Forecast
11.2.1. By Indication
11.2.2. By Embolic agents
11.2.3. By Types
11.2.4. By End-User
11.2.5. By Country
11.3. Market Attractiveness Index
11.4. MEA: Country Analysis
11.4.1. South Africa Embolotherapy Market Outlook
11.4.1.1. Market Size & Forecast
11.4.1.1.1. By Value
11.4.1.2. Market Share & Forecast
11.4.1.2.1. By Indication
11.4.1.2.2. By Embolic agents
11.4.1.2.3. By Types
11.4.1.2.4. By End-User
11.4.2. Saudi Arabia Embolotherapy Market Outlook
11.4.2.1. Market Size & Forecast
11.4.2.1.1. By Value
11.4.2.2. Market Share & Forecast
11.4.2.2.1. By Indication
11.4.2.2.2. By Embolic agents
11.4.2.2.3. By Types
11.4.2.2.4. By End-User
11.4.3. UAE Embolotherapy Market Outlook
11.4.3.1. Market Size & Forecast
11.4.3.1.1. By Value
11.4.3.2. Market Share & Forecast
11.4.3.2.1. By Indication
11.4.3.2.2. By Embolic agents
11.4.3.2.3. By Types
11.4.3.2.4. By End-User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Competition Outlook
14.2. Players Profiled (Leading Companies)
14.2.1. Abbott Laboratories
14.2.2. ABK Biomedical Inc
14.2.3. Acandis GmbH
14.2.4. AngioDynamics Inc
14.2.5. Becton Dickinson and Company
14.2.6. Boston Scientific Corporation
14.2.7. Cook Medical
14.2.8. Guerbet
14.2.9. Imbiotechnologies Ltd.
14.2.10. Johnson & Johnson
14.2.11. Kaneka Corporation
14.2.12. Medtronic
14.2.13. Meril Life Sciences Pvt. Ltd.
14.2.14. Merit Medical Systems
14.2.15. Merit Medical Systems, Inc.
14.2.16. Penumbra, Inc.
14.2.17. Simbionix USA Corporation
14.2.18. Sirtex Medical Limited
14.2.19. Stryker Corporation
14.2.20. Terumo Corporation
15. Strategic Recommendations16. About Us & Disclaimer
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Abbott Laboratories
  • ABK Biomedical Inc
  • Acandis GmbH
  • AngioDynamics Inc
  • Becton Dickinson and Company
  • Boston Scientific Corporation
  • Cook Medical
  • Guerbet
  • Imbiotechnologies Ltd.
  • Johnson & Johnson
  • Kaneka Corporation
  • Medtronic
  • Meril Life Sciences Pvt. Ltd.
  • Merit Medical Systems
  • Merit Medical Systems, Inc.
  • Penumbra, Inc.
  • Simbionix USA Corporation
  • Sirtex Medical Limited
  • Stryker Corporation
  • Terumo Corporation
Note: Product cover images may vary from those shown